Profile | GDS5420 / 209794_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 288.47 | 58 |
GSM1296119 | B_lesional_pre-dose | 149.76 | 47 |
GSM1296076 | C_lesional_pre-dose | 102.91 | 43 |
GSM1296092 | D_lesional_pre-dose | 167.7 | 51 |
GSM1296103 | E_lesional_pre-dose | 481.63 | 67 |
GSM1296078 | F_lesional_pre-dose | 87.99 | 41 |
GSM1296107 | G_lesional_pre-dose | 118.3 | 43 |
GSM1296109 | H_lesional_pre-dose | 65.6 | 33 |
GSM1296080 | I_lesional_pre-dose | 596.95 | 71 |
GSM1296090 | J_lesional_pre-dose | 270.83 | 58 |
GSM1296074 | K_lesional_pre-dose | 120.91 | 47 |
GSM1296111 | L_lesional_pre-dose | 26.88 | 18 |
GSM1296099 | M_lesional_pre-dose | 224.15 | 54 |
GSM1296086 | O_lesional_pre-dose | 141.23 | 48 |
GSM1296117 | P_lesional_pre-dose | 115.95 | 42 |
GSM1296113 | Q_lesional_pre-dose | 129.76 | 42 |
GSM1296096 | R_lesional_pre-dose | 196.62 | 52 |
GSM1296105 | S_lesional_pre-dose | 218.18 | 53 |
GSM1296098 | T_lesional_pre-dose | 411.43 | 64 |
GSM1296101 | U_lesional_pre-dose | 199.48 | 52 |
GSM1296121 | V_lesional_pre-dose | 115.38 | 43 |
GSM1296088 | W_lesional_pre-dose | 168.37 | 50 |
GSM1296082 | X_lesional_pre-dose | 141.84 | 49 |
GSM1296115 | Y_lesional_pre-dose | 64.24 | 33 |
GSM1296084 | Z_lesional_pre-dose | 177.48 | 51 |
GSM1296072 | B_lesional_day8 | 226.78 | 54 |
GSM1296069 | L_lesional_day8 | 60.22 | 30 |
GSM1296071 | P_lesional_day8 | 138.4 | 44 |
GSM1296070 | Y_lesional_day8 | 105.42 | 39 |
GSM1296073 | V_lesional_day8 | 85.1 | 38 |
GSM1296034 | A_lesional_day15 | 583.62 | 69 |
GSM1296041 | G_lesional_day15 | 82.17 | 37 |
GSM1296035 | R_lesional_day15 | 222.22 | 54 |
GSM1296038 | U_lesional_day15 | 252.09 | 56 |
GSM1296047 | B_lesional_day15 | 204.74 | 52 |
GSM1296039 | E_lesional_day15 | 225.33 | 55 |
GSM1296042 | H_lesional_day15 | 83.51 | 36 |
GSM1296043 | L_lesional_day15 | 86.32 | 36 |
GSM1296037 | M_lesional_day15 | 386.13 | 63 |
GSM1296046 | P_lesional_day15 | 173.51 | 48 |
GSM1296044 | Q_lesional_day15 | 155.86 | 46 |
GSM1296045 | Y_lesional_day15 | 146.06 | 45 |
GSM1296025 | C_lesional_day15 | 404.74 | 64 |
GSM1296033 | D_lesional_day15 | 343.89 | 61 |
GSM1296027 | I_lesional_day15 | 665.72 | 72 |
GSM1296032 | J_lesional_day15 | 291.54 | 58 |
GSM1296024 | K_lesional_day15 | 275.73 | 58 |
GSM1296031 | W_lesional_day15 | 123.27 | 44 |
GSM1296028 | X_lesional_day15 | 300.19 | 59 |
GSM1296029 | Z_lesional_day15 | 343.59 | 61 |
GSM1296026 | F_lesional_day15 | 234.85 | 56 |
GSM1296030 | O_lesional_day15 | 494 | 68 |
GSM1296040 | S_lesional_day15 | 442.88 | 65 |
GSM1296036 | T_lesional_day15 | 350.01 | 61 |
GSM1296048 | V_lesional_day15 | 141.8 | 46 |
GSM1296059 | A_lesional_day43 | 409.81 | 64 |
GSM1296066 | G_lesional_day43 | 173.1 | 49 |
GSM1296060 | R_lesional_day43 | 228.3 | 54 |
GSM1296063 | U_lesional_day43 | 135.02 | 46 |
GSM1296064 | E_lesional_day43 | 255.55 | 57 |
GSM1296067 | H_lesional_day43 | 204.79 | 51 |
GSM1296062 | M_lesional_day43 | 410.45 | 64 |
GSM1296068 | Q_lesional_day43 | 146.53 | 44 |
GSM1296050 | C_lesional_day43 | 114.67 | 43 |
GSM1296057 | D_lesional_day43 | 250.76 | 56 |
GSM1296052 | I_lesional_day43 | 582.52 | 70 |
GSM1296054 | J_lesional_day43 | 383.66 | 63 |
GSM1296049 | K_lesional_day43 | 273.56 | 58 |
GSM1296055 | W_lesional_day43 | 209.76 | 52 |
GSM1296053 | X_lesional_day43 | 606.63 | 70 |
GSM1296058 | Z_lesional_day43 | 412.43 | 64 |
GSM1296051 | F_lesional_day43 | 218.65 | 55 |
GSM1296056 | O_lesional_day43 | 182.3 | 52 |
GSM1296065 | S_lesional_day43 | 178.48 | 50 |
GSM1296061 | T_lesional_day43 | 332.72 | 60 |
GSM1296095 | A_non-lesional_pre-dose | 174.58 | 51 |
GSM1296120 | B_non-lesional_pre-dose | 180.77 | 49 |
GSM1296077 | C_non-lesional_pre-dose | 290.18 | 59 |
GSM1296093 | D_non-lesional_pre-dose | 257.77 | 56 |
GSM1296104 | E_non-lesional_pre-dose | 259.56 | 57 |
GSM1296079 | F_non-lesional_pre-dose | 242.98 | 56 |
GSM1296108 | G_non-lesional_pre-dose | 183.12 | 50 |
GSM1296110 | H_non-lesional_pre-dose | 99.23 | 38 |
GSM1296081 | I_non-lesional_pre-dose | 333.36 | 61 |
GSM1296091 | J_non-lesional_pre-dose | 303.86 | 60 |
GSM1296075 | K_non-lesional_pre-dose | 146.55 | 49 |
GSM1296112 | L_non-lesional_pre-dose | 217.25 | 51 |
GSM1296100 | M_non-lesional_pre-dose | 587.23 | 70 |
GSM1296087 | O_non-lesional_pre-dose | 450.88 | 66 |
GSM1296118 | P_non-lesional_pre-dose | 141.42 | 44 |
GSM1296114 | Q_non-lesional_pre-dose | 235.33 | 54 |
GSM1296097 | R_non-lesional_pre-dose | 213.68 | 53 |
GSM1296106 | S_non-lesional_pre-dose | 200.88 | 51 |
GSM1296102 | U_non-lesional_pre-dose | 208.62 | 52 |
GSM1296122 | V_non-lesional_pre-dose | 145.49 | 46 |
GSM1296089 | W_non-lesional_pre-dose | 228.47 | 54 |
GSM1296083 | X_non-lesional_pre-dose | 210.4 | 53 |
GSM1296116 | Y_non-lesional_pre-dose | 151.99 | 45 |
GSM1296085 | Z_non-lesional_pre-dose | 605.18 | 71 |